Related references
Note: Only part of the references are listed.Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae
Abraham Borer et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2012)
Nosocomial Outbreak of VIM-1-Producing Klebsiella pneumoniae Isolates of Multilocus Sequence Type 15: Molecular Basis, Clinical Risk Factors, and Outcome
Isabel Sanchez-Romero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Zubair A. Qureshi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Efficacy of Imipenem for the Treatment of Bacteremia Due to an OXA-48-Producing Klebsiella pneumoniae Isolate
Anne-Claire Maherault et al.
CLINICAL INFECTIOUS DISEASES (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Paritosh Prasad et al.
CLINICAL INFECTIOUS DISEASES (2012)
Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria
M. Akova et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
D. Ben-David et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
A Randomized, Double-Blind, Placebo-Controlled Trial of Selective Digestive Decontamination Using Oral Gentamicin and Oral Polymyxin E for Eradication of Carbapenem-Resistant Klebsiella pneumoniae Carriage
Lisa Saidel-Odes et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
A case of carbapenemase-producing Klebsiella pneumoniae in Australia
Nicholas R. Coatsworth et al.
PATHOLOGY (2012)
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation
M. D. Bergamasco et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Carbapenem resistance in Enterobacteriaceae: here is the storm!
Patrice Nordmann et al.
TRENDS IN MOLECULAR MEDICINE (2012)
In Vitro Interactions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development
Maria Souli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Neil Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
Metallo-β-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary-care hospital and long-term care facilities during 2008
R. Aschbacher et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
O. Zarkotou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
G. L. Daikos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1 producers
Beatrice Bercot et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Creeping baselines and adaptive resistance to antibiotics
Lucia Fernandez et al.
DRUG RESISTANCE UPDATES (2011)
Carbapenem-Resistant Klebsiella pneumoniae in Post-Acute-Care Facilities in Israel
Debby Ben-David et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay
Spyros Pournaras et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Adaptive resistance to cationic compounds in Pseudomonas aeruginosa
Anna Skiada et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
David M. Livermore et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10)
Panagiota Giakkoupi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Efficacy and safety of tigecycline: a systematic review and meta-analysis
Dafna Yahav et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae
Nimish Patel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?
Patrice Nordmann et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Metallo-β-lactamases: a last frontier for β-lactams?
Giuseppe Cornaglia et al.
LANCET INFECTIOUS DISEASES (2011)
Use of Meropenem by Continuous Infusion to Treat a Patient with a B/akpc-2-Positive Klebsiella pneumoniae Blood Stream Infection
Vanessa P. Ho et al.
SURGICAL INFECTIONS (2011)
A Call for Action: The Application of the International Health Regulations to the Global Threat of Antimicrobial Resistance
Didier Wernli et al.
PLOS MEDICINE (2011)
Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against Klebsiella pneumoniae Producing the KPC Carbapenemase versus That against Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model
Catharine C. Bulik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Updated Functional Classification of beta-Lactamases
Karen Bush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
Amelie Carrer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase-Producing Klebsiella pneumoniae
Catharine C. Bulik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
An Outbreak of Infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2-Producing K-pneumoniae in a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes
Maria Souli et al.
CLINICAL INFECTIOUS DISEASES (2010)
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
V. Miriagou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii: assessing their impact on organ transplantation
Gopi Patel et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2010)
Bloodstream Infections Caused by Metallo-β-Lactamase/Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae among Intensive Care Unit Patients in Greece: Risk Factors for Infection and Impact of Type of Resistance on Outcomes
Eleni Mouloudi et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo-β-lactamase
George L. Daikos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
Elizabeth B. Hirsch et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
Rajesh V. Dudhani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
Azza Elemam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin
Romney M. Humphries et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Karthikeyan K. Kumarasamy et al.
LANCET INFECTIOUS DISEASES (2010)
Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan
Abhijeet S. Nadkarni et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2009)
Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
George L. Daikos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland
Anna Baraniak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Crystal Structure of the OXA-48 β-Lactamase Reveals Mechanistic Diversity among Class D Carbapenemases
Jean-Denis Docquier et al.
CHEMISTRY & BIOLOGY (2009)
Infection with Panresistant Klebsiella pneumoniae: A Report of 2 Cases and a Brief Review of the Literature
Azza Elemam et al.
CLINICAL INFECTIOUS DISEASES (2009)
Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult Successful treatment with gentamicin and colistin
Shmuel Benenson et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2009)
Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system
Andrea Endimiani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Presence of the KPC Carbapenemase Gene in Enterobacteriaceae Causing Bacteremia and Its Correlation with In Vitro Carbapenem Susceptibility
Jonas Marschall et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Emergence in Italy of Klebsiella pneumoniae Sequence Type 258 Producing KPC-3 Carbapenemase
Tommaso Giani et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece)
H. C. Maltezou et al.
JOURNAL OF INFECTION (2009)
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Patrice Nordmann et al.
LANCET INFECTIOUS DISEASES (2009)
Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients
A. J. Mathers et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Spread of OXA-48-Positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey
Amelie Carrer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene
Thierry Naas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek university hospital
Maria Souli et al.
CLINICAL INFECTIOUS DISEASES (2008)
Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
N. Petrosillo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 β-lactamase-producing Klebsiella pneumoniae epidemic clone
Javier Cobo et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
A review of tigecycline - the first glycylcycline
Lance R. Peterson
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality
Mitchell J. Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-β-lactamase:: first Italian outbreak
Simone Cagnacci et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Ongoing epidemic of bla(VIM-1)-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey
M. Psichogiou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Alexandre Prehn Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
The continuing challenge of ESBLs
Federico Perez et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Crystal structure of KPC-2:: Insights into carbapenemase activity in class a β-lactamases
Wei Ke et al.
BIOCHEMISTRY (2007)
Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China
Ze-Qing Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Activity of imipenem against VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model
G. L. Daikos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases
George L. Daikos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients
Chonghua Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America
Maria Virginia Villegas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
Kenneth N. Agwuh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY:: molecular epidemiology and in vitro activity of polymyxin B and other agents
S Bratu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Revised Ambler classification of β-lactamases
BG Hall et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Metallo-β-lactamases:: the quiet before the storm?
TR Walsh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials
M Paul et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City
PA Bradford et al.
CLINICAL INFECTIOUS DISEASES (2004)
Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Colistin for Klebsiella pneumoniae-associated sepsis
A Karabinis et al.
CLINICAL INFECTIOUS DISEASES (2004)
Biological costs and mechanisms of fosfomycin resistance in Escherichia coli
AI Nilsson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
β lactam monotherapy versus β lactam-aminoglycoside combination therapy for fever with neutropenia:: systematic review and meta-analysis
M Paul et al.
BRITISH MEDICAL JOURNAL (2003)
Plasmid-determined AmpC-type beta-lactamases
A Philippon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying blaIMP-8 in a university medical center in Taiwan
JJ Yan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Share Paper
